Correlation Between Dogwood Therapeutics, and Amylyx Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Dogwood Therapeutics, and Amylyx Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dogwood Therapeutics, and Amylyx Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dogwood Therapeutics, and Amylyx Pharmaceuticals, you can compare the effects of market volatilities on Dogwood Therapeutics, and Amylyx Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dogwood Therapeutics, with a short position of Amylyx Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dogwood Therapeutics, and Amylyx Pharmaceuticals.
Diversification Opportunities for Dogwood Therapeutics, and Amylyx Pharmaceuticals
-0.47 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Dogwood and Amylyx is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Dogwood Therapeutics, and Amylyx Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amylyx Pharmaceuticals and Dogwood Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dogwood Therapeutics, are associated (or correlated) with Amylyx Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amylyx Pharmaceuticals has no effect on the direction of Dogwood Therapeutics, i.e., Dogwood Therapeutics, and Amylyx Pharmaceuticals go up and down completely randomly.
Pair Corralation between Dogwood Therapeutics, and Amylyx Pharmaceuticals
Given the investment horizon of 90 days Dogwood Therapeutics, is expected to under-perform the Amylyx Pharmaceuticals. In addition to that, Dogwood Therapeutics, is 2.31 times more volatile than Amylyx Pharmaceuticals. It trades about -0.09 of its total potential returns per unit of risk. Amylyx Pharmaceuticals is currently generating about 0.09 per unit of volatility. If you would invest 527.00 in Amylyx Pharmaceuticals on August 31, 2024 and sell it today you would earn a total of 47.00 from holding Amylyx Pharmaceuticals or generate 8.92% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 95.65% |
| Values | Daily Returns |
Dogwood Therapeutics, vs. Amylyx Pharmaceuticals
Performance |
| Timeline |
| Dogwood Therapeutics, |
| Amylyx Pharmaceuticals |
Dogwood Therapeutics, and Amylyx Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dogwood Therapeutics, and Amylyx Pharmaceuticals
The main advantage of trading using opposite Dogwood Therapeutics, and Amylyx Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dogwood Therapeutics, position performs unexpectedly, Amylyx Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amylyx Pharmaceuticals will offset losses from the drop in Amylyx Pharmaceuticals' long position.| Dogwood Therapeutics, vs. Viracta Therapeutics | Dogwood Therapeutics, vs. Viking Therapeutics | Dogwood Therapeutics, vs. Dyadic International | Dogwood Therapeutics, vs. Surrozen Warrant |
| Amylyx Pharmaceuticals vs. Dogwood Therapeutics, | Amylyx Pharmaceuticals vs. Enlivex Therapeutics | Amylyx Pharmaceuticals vs. Ensysce Biosciences | Amylyx Pharmaceuticals vs. Entero Therapeutics, |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Transaction History View history of all your transactions and understand their impact on performance |